Not all cancer patients need chemo — Ataraxis AI raised $20M to personalize treatment

Artificial intelligence is a major trend of cancer care and mostly focus on detection of cancer at the possible stage. It makes a lot of meaning, the cancer is less severe before it is detected.

However, very few people are asking another basic question: If anyone has cancer, is invasive treatment like chemotherapy? This is the problem Attarks is trying to solve AI.

The New York -based startup is only concentrated on using AI to properly predict their cancer results only if a patient is cancer. If there is a small chance of returning cancer, chemo can be fully avoided while avoiding the infamous side effects of treatment – saving a lot of money.

Ataruxis AI is now planning to launch our oncologist in their first commercial examination, breast cancer, its co-founder, Jane Witovsky TechCrunch. To strengthen the launch and extend to other types of cancer, the startup raised in a 20.4 million dollar series, which has called TechCrunch exclusively.

The round led by Thiel Bio, Founding Fund, Floating Point, Bartelsman and Giant Ventures and Existing Investors Giant Ventures and AIX Venture with the participation of clear initiatives. Attorxis Raised Round $ 4 million from stealth last year.

The Attorxis was co-founded by Witoski and Assistant Professor of NYO Medical School, Crazistph Geras, who focused on AI.

Atarkis Tech is powered by an AI model that extracts data from high-resolution images of cancer cells. The model is trained on several million real images from thousands of patients, Witoski. A recent study has shown that the technology of Ataraxis was 30% more accurate than the current quality of breast cancer per attaraxis per attaraxis.

Long -term, Atarkis has a great ambition. Its tests by 2030 want to have at least the impact on the at least new cancer IT Meta’s main AI scientist Ian Lacoon As AI advisor.

“I think we are basically trying to create the AI ​​Frontier Lab in Ataraxis, but for healthcare applications,” Witovsky said. “Because many of these problems need a lot of fancy technology” “

AI Boom has crowded funds for cancer care startups. Laboratory Raising $ 22 million Patients to help find out their treatment plan in May 2024, for example. Ai -driven drug invention agencies are also a Beiivo in a cancer place like Mans AI 24.6 million dollars have been collected in January 2025 And LinkedIn co-founder Reid Hoffman was co-founded.